Results 271 to 280 of about 144,401 (340)

Risk of Type II Diabetes Mellitus Among B‐Cell Non‐Hodgkin's Lymphoma Survivors

open access: yesCancer Medicine, Volume 15, Issue 1, January 2026.
ABSTRACT Purpose Advancing therapies have increased B‐cell Non‐Hodgkin's Lymphoma (B‐NHL) patient survival. However, data are limited on the risk of type II diabetes mellitus (type II DM) in adult survivors following treatment. This study examines the risk of type II DM among a Utah population of B‐NHL survivors, compared to the general population ...
Ellenor Chi   +9 more
wiley   +1 more source

Exploring Stakeholder Perceptions and Experience of Biosimilar Insulin Switching: A Scoping Review

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 1, January 2026.
This scoping review has systematically mapped the existing literature on stakeholder perceptions and experience of biosimilar insulin switches. It shows that there is a lack of high‐quality context‐specific research in this area, and more needs to be done to understand this topic. ABSTRACT Background The option to switch patients to more cost‐effective
Ben Hindley   +4 more
wiley   +1 more source

Assessing Machine Learning for Diagnostic Classification of Hypertension Types Identified by Ambulatory Blood Pressure Monitoring. [PDF]

open access: yesCJC Open
Tran TQB   +17 more
europepmc   +1 more source

The Effect of Chronotherapy on Clinical Outcomes in Hypertensive Patients: A Systematic Review and Meta‐Analysis Comparing Bedtime Versus Morning Dosing of Antihypertensive Drugs

open access: yesHealth Science Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Background and Aims This systematic review and meta‐analysis aimed to compare the clinical outcomes of antihypertensive medication administration at bedtime versus morning, focusing on major adverse cardiovascular events (MACE), mortality, and secondary cardiovascular outcomes in hypertensive patients.
Pouria Azami   +6 more
wiley   +1 more source

From Molecule to Meaning: Neuronopathic Biomarkers and Clinical Relevance in GM1

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 1, January 2026.
ABSTRACT GM1 gangliosidosis is a rare, progressively neurodegenerative lysosomal storage disorder characterized by profound central nervous system involvement and substantial clinical heterogeneity. The development of reliable biomarkers is essential for tracking disease progression, stratifying patients, and advancing clinical trial readiness. Primary
Krista Casazza   +3 more
wiley   +1 more source

Reimagining Outcomes: A Perspective Review of Advances in Remote Monitoring Technologies in Post‐Arthroplasty Patient Care

open access: yesJournal of Orthopaedic Research, Volume 44, Issue 1, January 2026.
ABSTRACT Arthroplasty surgery is a common and successful end‐stage intervention for advanced osteoarthritis. Yet, postoperative outcomes vary significantly among patients, leading to a plethora of measures and associated measurement approaches to monitor patient outcomes. Traditional approaches rely heavily on patient‐reported outcome measures (PROMs),
Janie L. Astephen Wilson   +1 more
wiley   +1 more source

Home - About - Disclaimer - Privacy